MAGE revisited: Evaluation of glucose variability with once daily glargine vs NPH insulin in type 2 diabetes

被引:0
|
作者
Silvani, G. [1 ]
Acquati, S. [1 ]
Manini, R. [1 ]
Ragazzini, C. [1 ]
Taroni, S. [1 ]
Donadio, F. [1 ]
Buci, L. [1 ]
Gagliardi, L. [1 ]
Tartaglia, A. [1 ]
Nizzoli, M. [1 ]
机构
[1] GB Morgagni L Pierantoni Hosp, Forli, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
978
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes
    Bolli, G. B.
    Songini, M.
    Trovati, M.
    Del Prato, S.
    Ghirlanda, G.
    Cordera, R.
    Trevisan, R.
    Riccardi, G.
    Noacco, C.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2009, 19 (08) : 571 - 579
  • [2] Comparing efficiency of insulin glargine vs. NPH insulin in patients with type 2 diabetes
    Kodela, B.
    Petrovic, J.
    Velickovic-Radovanovic, R.
    Lilic, R.
    Radenkovic, S.
    Dedovic, I
    VALUE IN HEALTH, 2007, 10 (06) : A254 - A254
  • [3] Duration of diabetes and hypoglycaemia rates in type 2 diabetes patients treated with insulin glargine vs NPH insulin
    Dailey, G.
    Aurand, L.
    Garg, S.
    DIABETOLOGIA, 2011, 54 : S262 - S262
  • [4] Therapy in type 2 diabetes: Insulin glargine vs. 2 NPH insulin both in combination with glimepiride
    Eliaschewitz, FG
    Calvo, C
    Valbuena, H
    Ruiz, M
    Aschner, P
    Villena, J
    Ramirez, LA
    Jimenez, J
    ARCHIVES OF MEDICAL RESEARCH, 2006, 37 (04) : 495 - 501
  • [5] Fasting blood glucose for insulin adjustment with insulin glargine or NPH insulin combined with sulphonylurea in Type 2 diabetes
    Haupt, A
    Eckert, H
    Schweitzer, MA
    Peiker, J
    Häring, HU
    Fritsche, A
    DIABETOLOGIA, 2004, 47 : A269 - A269
  • [6] Plasma glucose profiles in patients with type 1 diabetes treated with insulin glargine or NPH insulin
    Garg, SK
    Chase, HP
    Marshall, G
    DIABETES, 2001, 50 : A435 - A436
  • [7] Hypoglycemia and postprandial glucose are lower with insulin glargine versus NPH insulin in older type 2 diabetes patients
    Fritsche, A
    Dailey, G
    Lin, Z
    Murray, F
    Häring, H
    Rosenstock, J
    GERONTOLOGIST, 2004, 44 : 221 - 221
  • [8] Economic evaluation of the use of insulin glargine compared with NPH insulin in patients with Type 2 diabetes in Spain
    Rodríguez, J
    Terrés, CR
    Bolinder, B
    de Pablos, P
    DIABETOLOGIA, 2004, 47 : A344 - A344
  • [9] THE EFFECT OF GLARGINE AND NPH INSULIN IN PATIENTS WITH DIABETES MELLITUS TYPE 2
    Nechevska, L.
    Nechevski, M.
    Nechevska, E.
    Boskovski, B.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [10] Insulin lispro mix 25/75 twice daily (LM25) vs basal insulin glargine once daily and prandial insulin lispro once daily (BP) in type 2 diabetes: insulin intensification
    Tinahones, F. J.
    Gross, J. L.
    Onaca, A.
    Zhou, Z.
    Cleall, S.
    Rodriguez, A.
    DIABETOLOGIA, 2013, 56 : S412 - S412